Found 242 with Last Name = 'kunos' and Initial = 'g' TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 2.70nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 3.20nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 3.60nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 5nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 5.70nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 5.70nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 6.5nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 6.5nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 6.5nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 7nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 7nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 7nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 7.70nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 7.70nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 7.90nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 7.90nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 7.90nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 8nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 8nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 8.10nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 9nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 9nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 9nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 10nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 10nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 10nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 10nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 10nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 10nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 10nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 11nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 13nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 13nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 13nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 15nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 15nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 15nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 16nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 18nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 18nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 18nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 18nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 18nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 19nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 19nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 23nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 26nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 26nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 26nMAssay Description:Displacement of [3H]CP55940 from mouse brain CB1R expressed in CHOK1 cell membranesMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Mus musculus (Mouse))
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 26nMAssay Description:Measuring its tissue levels 1 hour after administration of 10 mg/kg to mice, plasma levels were comparable after oral or i.p. administration (indicat...More data for this Ligand-Target Pair
